These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 9164416)
61. Determination of oral rifampin pharmacokinetic parameters in Mexicans and comparison with other populations: absence of evidence for interethnic variability. Flores-Murrieta FJ; Castañeda-Hernández G; Herrera JE; Hong E Arch Med Res; 1994; 25(4):381-5. PubMed ID: 7858395 [TBL] [Abstract][Full Text] [Related]
63. Single dose kinetics of rifampicin and isoniazid in well-nourished and malnourished patients of tuberculosis. Garg SK; Dhand R; Malik SK; Kalra S; Gupta PH; Jha VK; Shukla VK; Lal R Int J Clin Pharmacol Ther Toxicol; 1988 Aug; 26(8):417-20. PubMed ID: 3220617 [TBL] [Abstract][Full Text] [Related]
64. Effects of erythromycin or rifampin on losartan pharmacokinetics in healthy volunteers. Williamson KM; Patterson JH; McQueen RH; Adams KF; Pieper JA Clin Pharmacol Ther; 1998 Mar; 63(3):316-23. PubMed ID: 9542475 [TBL] [Abstract][Full Text] [Related]
65. Simple, rapid and sensitive high-performance liquid chromatographic determination of delavirdine and its N-desisopropyl metabolite in human plasma. Staton BA; Johnson MG; Friis JM; Adams WJ J Chromatogr B Biomed Appl; 1995 Jun; 668(1):99-106. PubMed ID: 7550987 [TBL] [Abstract][Full Text] [Related]
66. Influence of Moringa oleifera on pharmacokinetic disposition of rifampicin using HPLC-PDA method: a pre-clinical study. Pal A; Bawankule DU; Darokar MP; Gupta SC; Arya JS; Shanker K; Gupta MM; Yadav NP; Singh Khanuja SP Biomed Chromatogr; 2011 Jun; 25(6):641-5. PubMed ID: 20845375 [TBL] [Abstract][Full Text] [Related]
67. Multiple-Dose Pharmacokinetics of Delavirdine Mesylate and Didanosine in HIV-Infected Patients. Morse GD; Cohn SE; Shelton MJ; Greisberger C; Cox SR; Della-Coletta AA; Freimuth WW; Reichman RC Clin Drug Investig; 2003; 23(5):323-8. PubMed ID: 17535044 [TBL] [Abstract][Full Text] [Related]
68. Pharmacokinetics of rifampicin in Mexican patients with tuberculosis and healthy volunteers. Medellín-Garibay SE; Milán-Segovia Rdel C; Magaña-Aquino M; Portales-Pérez DP; Romano-Moreno S J Pharm Pharmacol; 2014 Oct; 66(10):1421-8. PubMed ID: 24841364 [TBL] [Abstract][Full Text] [Related]
69. Increasing nevirapine dose can overcome reduced bioavailability due to rifampicin coadministration. Ramachandran G; Hemanthkumar AK; Rajasekaran S; Padmapriyadarsini C; Narendran G; Sukumar B; Sathishnarayan S; Raja K; Kumaraswami V; Swaminathan S J Acquir Immune Defic Syndr; 2006 May; 42(1):36-41. PubMed ID: 16639340 [TBL] [Abstract][Full Text] [Related]
70. Effects of Pluronic F68 and Labrasol on the intestinal absorption and pharmacokinetics of rifampicin in rats. Ma L; Wei Y; Zhou Y; Ma X; Wu X Arch Pharm Res; 2011 Nov; 34(11):1939-43. PubMed ID: 22139693 [TBL] [Abstract][Full Text] [Related]
71. Safety, tolerance, and pharmacokinetics of atevirdine mesylate (U-87201E) in asymptomatic human immunodeficiency virus-infected patients. Been-Tiktak AM; Vrehen HM; Schneider MM; van der Feltz M; Branger T; Ward P; Cox SR; Harry JD; Borleffs JC Antimicrob Agents Chemother; 1995 Mar; 39(3):602-7. PubMed ID: 7793859 [TBL] [Abstract][Full Text] [Related]
72. Characterization of hepatic cytochrome p4503A activity in patients with end-stage renal disease. Dowling TC; Briglia AE; Fink JC; Hanes DS; Light PD; Stackiewicz L; Karyekar CS; Eddington ND; Weir MR; Henrich WL Clin Pharmacol Ther; 2003 May; 73(5):427-34. PubMed ID: 12732843 [TBL] [Abstract][Full Text] [Related]
73. Tamoxifen and toremifene concentrations in plasma are greatly decreased by rifampin. Kivistö KT; Villikka K; Nyman L; Anttila M; Neuvonen PJ Clin Pharmacol Ther; 1998 Dec; 64(6):648-54. PubMed ID: 9871429 [TBL] [Abstract][Full Text] [Related]
74. Inhibitory and inductive effects of rifampin on the pharmacokinetics of bosentan in healthy subjects. van Giersbergen PL; Treiber A; Schneiter R; Dietrich H; Dingemanse J Clin Pharmacol Ther; 2007 Mar; 81(3):414-9. PubMed ID: 17251982 [TBL] [Abstract][Full Text] [Related]
76. Delavirdine approved for use in treating HIV. J Am Osteopath Assoc; 1997 May; 97(5):266. PubMed ID: 9195786 [No Abstract] [Full Text] [Related]
77. Pharmacokinetic interactions between efavirenz and rifampicin in the treatment of HIV and tuberculosis: one size does not fit all. Brennan-Benson P; Lyus R; Harrison T; Pakianathan M; Macallan D AIDS; 2005 Sep; 19(14):1541-3. PubMed ID: 16135909 [TBL] [Abstract][Full Text] [Related]
78. [Pharmacokinetic interaction between itraconazole and rifampin in Yucatan miniature pigs]. Kaltenbach G; Levêque D; Peter JD; Salmon J; Elkhaili H; Cavalier A; Salmon Y; Monteil H; Jehl F Pathol Biol (Paris); 1996 May; 44(5):379-83. PubMed ID: 8758480 [TBL] [Abstract][Full Text] [Related]